NBCD attending JPM 2023

January 09, 2023 NBCD will be participating in the virtual part of JPM 2023, represented by Chief Commercial Officer, Casper Clemmensen, who will be sharing our unique expertise and insights on OA.

As a company dedicated to clinical drug development, we are always looking for ways to connect with other professionals in the healthcare industry and learn about the latest developments in our field.

Reach out to Casper at ccl@nbcd.com to learn more, or request a meeting through the platform.